Loading...
Please wait, while we are loading the content...
Similar Documents
Gemigliptin: An Update of Its Clinical Use in the Management of Type 2 Diabetes Mellitus
| Content Provider | Semantic Scholar |
|---|---|
| Author | Kim, Sung-Ho Yoo, Jung-Hwa Park, Cheol Young |
| Copyright Year | 2016 |
| Abstract | Dipeptidyl peptidase-4 (DPP-4) inhibitors are a new class of oral antidiabetic agent for the treatment of type 2 diabetes mellitus. They increase endogenous levels of incretin hormones, which stimulate glucose-dependent insulin secretion, decrease glucagon secretion, and contribute to reducing postprandial hyperglycemia. Although DPP-4 inhibitors have similar benefits, they can be differentiated in terms of their chemical structure, pharmacology, efficacy and safety profiles, and clinical considerations. Gemigliptin (brand name: Zemiglo), developed by LG Life Sciences, is a potent, selective, competitive, and long acting DPP-4 inhibitor. Various studies have shown that gemigliptin is an optimized DPP-4 inhibitor in terms of efficacy, safety, and patient compliance for treatment of type 2 diabetes mellitus. In this review, we summarize the characteristics of gemigliptin and discuss its potential benefits in clinical practice. |
| Starting Page | 339 |
| Ending Page | 353 |
| Page Count | 15 |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-339.pdf |
| Alternate Webpage(s) | https://www.e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-40-e29.pdf |
| PubMed reference number | 27766241v1 |
| Volume Number | 40 |
| Journal | Diabetes & metabolism journal |
| Language | English |
| Access Restriction | Open |
| Subject Keyword | Antidiabetics Chemical Structure Compliance behavior Diabetes Mellitus Diabetes Mellitus, Non-Insulin-Dependent Dipeptidyl Peptidase-4 Inhibitor Dipeptidyl-Peptidase IV Glucose Hyperglycemia Incretins Pharmacology Proprietary Name benefit gemigliptin glucagon secretion insulin secretion |
| Content Type | Text |
| Resource Type | Article |